Michael A. Fischer, MD, MS
Professor
Boston University Chobanian & Avedisian School of Medicine
Medicine
General Internal Medicine

MD, Yale University School of Medicine
MS, Harvard School of Public Health
AB, Harvard College

Pronouns: he/him/his



Michael Fischer, MD, MS is Chief of the Section of General Internal Medicine at Boston Medical Center/Chobanian and Avedisian School of Medicine. He is a primary care physician and health services researcher with expertise in developing and evaluating interventions to increase the use of evidence-based medical practices.

Dr. Fischer began his career at Brigham and Women’s Hospital, conducting research evaluating medication adherence; the appropriate use of prescription drugs; dissemination and implementation of evidence-based practices; prescription drug reimbursement policy; and the impact of electronic prescribing. He is the Director of the National Resource Center for Academic Detailing (www.NaRCAD.org), an initiative supported by the Agency for Health Care Research and Quality and the Centers for Disease Control and Prevention to assist organizations implementing interventions to improve health care quality and patient outcomes.

Diversity, Equity, Inclusion and Accessibility

Support for DEIA represents a core value for the Section of General Internal Medicine and in my own work. We are proud of the diversity embodied in our Section and in our commitment to equity, inclusion, and accessibility, but we all recognize that we must continue to work to enhance DEIA across the profession and the institution.

Within the Section, work on DEIA includes increasing transparency and ensuring equity of opportunity. We have initiated a new process for all available leadership positions, in collaboration with the Office of Equity, Vitality, and Inclusion. This will ensure that all leadership opportunities are posted and communicated and that applications, interviews, and decision-making about the positions occur with consistency. To support these efforts, we are gathering more complete data on the demographics of our faculty and staff, so that we can hold ourselves accountable for achieving these goals.

I currently serve as the co-sponsor for the BMC Equity Accelerator’s new initiative to promote equity in diabetes care and outcomes. Faculty and staff from our Section and across BMC are working with community partners to develop, implement, and evaluate interventions address the disparities in prevention, diagnosis, and treatment of diabetes.

Throughout my career I have mentored across differences with trainees and faculty, focusing on the ways in which I can provide support and serve as a champion for mentees and other colleagues.

Section Chief
Boston University Chobanian & Avedisian School of Medicine
Medicine
General Internal Medicine




NaRCAD''s International Conference Series: An Innovative Model to Advance the Field of Clinical Outreach Education
09/30/2022 - 09/29/2024 (PI)
Agency for Healthcare Research and Quality/DHHS
1R13HS028936-01A1

Demonstrating, testing, and disseminating a sustainable model for academic detailing programs
10/01/2021 - 07/31/2024 (PI)
Agency for Healthcare Research and Quality/DHHS
5R18HS026177-06

ACcelerating Equity in Diabetes (ACE Diabetes)
09/01/2022 - 03/01/2024 (PI)
Institute for Healthcare Improvement BCBS

Research Grants to Identify Effective Strategies for Opioid Overdose Prevention
09/30/2021 - 09/29/2023 (PI)
National Center for Chronic Disease Prevention & Health Promo./CDC/DHHS
5R01CE003153-03

Refinement and adaptation of reinforcement learning to personalize behavioral messaging for healthy habits
06/01/2022 - 05/31/2023 (PI)
Brigham and Womens Hospital National Institute o
5P30AG064199-04

Innovation in Academic Detailing to Improve Health Care Quality and Outcomes: NaRCAD International Conference Series on Academic Detailing
10/01/2021 - 07/31/2022 (PI)
Agency for Healthcare Research and Quality/DHHS
7R13HS026829-04

NACCHO CONTRACT # 2022- 022807 - Harm Reduction Project
06/10/2022 - 06/30/2022 (PI)
National Association of County & City Health Officials


Title


Yr Title Project-Sub Proj Pubs
2024 Boston Health Equity & community-Aligned Learning Health System (Boston-HEALHS) 1P30HS029752-01
2024 Administrative Core (AC) 1P30HS029752-01-7503
2023 NaRCAD's International Conference Series: An Innovative Model to Advance the Field of Clinical Outreach Education 5R13HS028936-02
2023 Demonstrating, testing, and disseminating a sustainable model for academic detailing programs 5R18HS026177-06
2022 Research Grants to Identify Effective Strategies for Opioid Overdose Prevention 1R01CE003529-01
2022 Demonstrating, testing, and disseminating a sustainable model for academic detailing programs 5R18HS026177-05
2021 Demonstrating, testing, and disseminating a sustainable model for academic detailing programs 7R18HS026177-04
2021 Engaging clinicians to improve opioid safety and reduce overdose risk 5R01CE003153-03
2021 Demonstrating, testing, and disseminating a sustainable model for academic detailing programs 5R18HS026177-03
2021 Innovation in Academic Detailing to Improve Health Care Quality and Outcomes: NaRCAD International Conference Series on Academic Detailing 7R13HS026829-04
Showing 10 of 32 results. Show All Results

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Cromer SJ, Steiner B, York C, Mastrorilli J, Lake GA, Leibowitz S, Simmons L, Steppel-Reznik J, Low G, Fischer MA, Patorno E, Wexler DJ. Successful implementation of a stakeholder engagement program for pharmacoepidemiologic research. Pharmacoepidemiol Drug Saf. 2024 Jan; 33(1):e5727. PMID: 37985010
     
  2. Brown T, Lee JY, Guzman A, Fischer MA, Friedberg MW, Chua KP, Linder JA. Prevalence and appropriateness of in-person versus not-in-person ambulatory antibiotic prescribing in an integrated academic health system: A cohort study. PLoS One. 2023; 18(7):e0289303. PMID: 37498818; PMCID: PMC10374053; DOI: 10.1371/journal.pone.0289303;
     
  3. Hendricks MA, El Ibrahimi S, Ritter GA, Flores D, Fischer MA, Weiss RD, Wright DA, Weiner SG. Association of Household Opioid Availability With Opioid Overdose. JAMA Netw Open. 2023 Mar 01; 6(3):e233385. PMID: 36930154; PMCID: PMC10024199; DOI: 10.1001/jamanetworkopen.2023.3385;
     
  4. Evins AE, Cather C, Maravic MC, Reyering S, Pachas GN, Thorndike AN, Levy DE, Fung V, Fischer MA, Schnitzer K, Pratt S, Fetters MD, Deeb B, Potter K, Schoenfeld DA. A Pragmatic Cluster-Randomized Trial of Provider Education and Community Health Worker Support for Tobacco Cessation. Psychiatr Serv. 2023 Apr 01; 74(4):365-373. PMID: 36349498
     
  5. Guzman A, Brown T, Lee JY, Fischer MA, Friedberg MW, Chua KP, Linder JA. Look-Back and Look-Forward Durations and the Apparent Appropriateness of Ambulatory Antibiotic Prescribing. Antibiotics (Basel). 2022 Nov 04; 11(11). PMID: 36358209; PMCID: PMC9686988; DOI: 10.3390/antibiotics11111554;
     
  6. Haff N, Choudhry NK, Isaac T, Bhatkhande G, Jackevicius CA, Fischer MA, Solomon DH, Sequist TD, Lauffenburger JC. Disagreement between pharmacy claims and direct interview to identify patients with non-adherence to chronic cardiometabolic medications. Am Heart J. 2023 Feb; 256:51-59. PMID: 36780373; PMCID: PMC10281352; DOI: 10.1016/j.ahj.2022.10.083;
     
  7. Wang J, Gagne JJ, Kattinakere-Sreedhara S, Fischer MA, Bykov K. Association between initiation of fluoroquinolones and hospital admission or emergency department visit for suicidality: population based cohort study. BMJ. 2022 Oct 04; 379:e069931. PMID: 36195324; PMCID: PMC9530980; DOI: 10.1136/bmj-2021-069931;
     
  8. Messinger JC, Kesselheim AS, Vine SM, Fischer MA, Barenie RE. Associations Between Copays, Coverage Limits for Naloxone, and Prescribing in Medicaid. Subst Abuse. 2022; 16:11782218221126972. PMID: 36199698; PMCID: PMC9528040; DOI: 10.1177/11782218221126972;
     
  9. Weiner SG, Hendricks MA, El Ibrahimi S, Ritter GA, Hallvik SE, Hildebran C, Weiss RD, Boyer EW, Flores DP, Nelson LS, Kreiner PW, Fischer MA. Opioid-related overdose and chronic use following an initial prescription of hydrocodone versus oxycodone. PLoS One. 2022; 17(4):e0266561. PMID: 35381052; PMCID: PMC8982846; DOI: 10.1371/journal.pone.0266561;
     
  10. Cram P, Selker H, Carnahan J, Romero-Brufau S, Fischer MA. Getting to 100%: Research Priorities and Unanswered Questions to Inform the US Debate on Universal Health Insurance Coverage. J Gen Intern Med. 2022 03; 37(4):949-953. PMID: 35060003; PMCID: PMC8904700; DOI: 10.1007/s11606-021-07234-1;
     
Showing 10 of 166 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 166 publications over 24 distinct years, with a maximum of 12 publications in 2010 and 2014

YearPublications
19911
19951
20021
20032
20044
20054
20067
20078
20085
20092
201012
20117
20129
20138
201412
201511
20168
20179
20189
201910
202011
202111
202211
20233


2012 National Association of Chain Drug Stores Foundation: Excellence in Patient Care and Research Award
2006 Blue Cross Blue Shield of Massachusetts: Excellence in Primary Care Honoree
2002 BWH, Boston, MA: Partners in Excellence Award: Leadership and Innovation
1997 Yale University School of Medicine, New Haven CT: Alpha Omega Alpha
1997 Yale University School of Medicine, New Haven CT: John P. Peters Prize for Outstanding Thesis
1997 Yale University School of Medicine, New Haven CT: Farr Scholar
1992 Harvard College, Boston, MA: Magna Cum Laude
1988 Harvard College, Boston, MA: Harvard National Scholar
Contact for Mentoring:

801 Massachusetts Ave
Boston MA 02118
Google Map


Fischer's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department